Clinical risk management of the rapid-cycling bipolar patient

Harvard Review of Psychiatry

Volumn 4, Issue 5, 1997, Pages 245-254

  Simon, Robert I ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; PIMOZIDE; THIORIDAZINE;

BIPOLAR DEPRESSION; HUMAN; INFORMED CONSENT; LAW; MANAGEMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIOLENCE;

EID: 0031016968     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229709030551     Document Type: Review

References (63)

1. McElroy S, Keck PE. Rapid cycling. In: Dunner DL, ed. Current psychiatric therapy. Philadelphia: Saunders, 1993;226-31.
2. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152: 1130-8.
3. Anonymous. Benefacts: a message from the APA-sponsored professional liability insurance program. Psychiatr News 1996 Apr 19:26.
4. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
5. Kukopulos A, Caliari B, Tundo A, Minnai G, Floris G, Reginaldi D, et al. Rapid cyclers, temperament, and antidepressants. Compr Psychiatry 1983;24:249-58.
6. American Psychiatric Association. Rapid-cycling specifier. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994:390-1.
7. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988;145:179-84.
8. Fawcett J, Scheftner W, Clark D, Hedeker D, Gibbons R, Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am J Psychiatry 1987;144:35-40.
9. Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974;30:229-33.
10. Alarcon RD. Rapid cycling affective disorders: a clinical review. Compr Psychiatry 1985;26:522-40.
11. Calabrese JR, Woyshville MJ. A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry 1995; 56(suppl 3):11-8.
12. Keck P. The biology and treatment of rapid cycling bipolar disorders. Presented at the Caribbean Psychopharmacology Congress, St Martin, 17 February 1995.
13. Fawcett J. Suicide risk factors in panic disorder. J Clin Psychiatry 1992;53:9-13.
14. Brady KT, Sonne SC. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995;56(suppl 3):19-24.
15. Simon RI, Sadoff RL. Psychiatric malpractice: cases and comments for clinicians. Washington, DC: American Psychiatric Press, 1992.
16. Simon RI. Clinical psychiatry and the law. 2nd ed. Washington, DC: American Psychiatric Press, 1992.
17. Simon RI. Innovative psychiatric therapies and legal uncertainty: a survival guide for clinicians. Psychiatr Ann 1993;23: 473-9.
18. Macbeth JE, Wheeler AM, Sither JW, Onek JN. Legal and risk management issues in the practice of psychiatry. Malpractice. Washington, DC: Psychiatrists' Purchasing Group, 1994.
19. Anonymous. Advisory committee recommends mania indication for divalproex sodium. Psychiatr Times 1995 Mar:6.
20. Marangell LB, Yudofsky SC. Developments in the treatment of bipolar disorder. Prim Psychiatry 1995;2:32-41.
21. Bender KJ. NIMH seeks improved pharmacotherapy for children. Psychiatr Times 1995 Mar:40.
22. Ramon v Farr, 770 P2d 131 (Utah 1989).
23. Schloendorff v Society of New York Hospital, 211 NY 125, 105 NE 92 (1914).
24. Bing v Thunig, 2 NY2d 656, 143 NE2d 3, 163 NYS2d 3 (1957).
25. Natanson v Kline, 186 Kan 393, 350 P2d 1093 (1960).
26. Canterbury v Spence, 464 F2d 772 (DC Cir 1972).
27. Spence v Canterbury, 409 US 1064 (1972).
28. Cobbs v Grant, 8 Cal 3d 229, 104 Cal Rptr 505, 502 P2d 1 (1972).
29. Gibbs RF. Informed consent: what it is and how to obtain it. Leg Aspects Med Pract 1987;15(Aug):1-4.
30. Klein v Biscup, 1996 Ohio App. Lexis 511.
31. Hondroulis v Schuhmacher, 553 So 3d 398 (La 1988).
32. Public Health Trust of Dade County v Valcin, 507 So 2d 596 (Fla 1987).
33. Appelbaum PS, Gutheil TG. Clinical handbook of psychiatry and the law. 2nd ed. Baltimore: Williams & Wilkins, 1991.
34. Brakel SJ, Parry J, Weiner BA. The mentally disabled and the law. 3rd ed. Chicago: American Bar Foundation, 1985.
35. Buda M, Tsuang MT. The epidemiology of suicide: implications for clinical practice. In: Blumenthal SJ, Kupfer DJ, eds. Suicide over the life cycle. Washington, DC: American Psychiatric Press, 1990:17-37.
36. Tardiff K. Violence by psychiatric patients. In: Simon RI, ed. American Psychiatric Press review of clinical psychiatry and the law, vol 2. Washington, DC: American Psychiatric Press, 1991:175-233.
37. Simon RI. Clinical risk management of suicidal patients: assessing the unpredictable. In: Simon RI, ed. American Psychiatric Press review of clinical psychiatry and the law, vol 3. Washington, DC: American Psychiatric Press, 1992:3-63.
38. Fawcett J. Predictors of early suicide: identification and appropriate intervention. J Clin Psychiatry 1988;49(10 suppl):7-9.
39. Fawcett J, Scheftner WA, Fogg L, Clark DC, Young MA, Hedeker D, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990;147:1189-94.
40. Teicher MH, Glod C, Cole J. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;52:294-9.
41. Mann J, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry 1991;48:1027-33.
42. Fava M, Rosenbaum JF. Suicidality and fluoxetine: is there a relationship? J Clin Psychiatry 1992;52:108-11.
43. Warshaw MG, Keller MB. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry 1996;57:158-66.
44. Fentress v Shea Communications, Inc, Jefferson [Kentucky] Circuit Court, 90-CI-06033, 1990.
45. Blumenthal SJ. An overview and synopsis of risk factors, assessment, and treatment of suicidal patients over the life cycle. In: Blumenthal SJ, Kupfer DJ, ed. Suicide over the life cycle: risk factors, assessment, and treatment of suicidal patients. Washington DC: American Psychiatric Press, 1990:685-733.
46. Tarasoff v Regents of University of California, 237 Cal 3d 425, 551 P2d 334 (1976).
47. Appelbaum PS, Zonana H, Bonnie R, Roth LH. Statutory approaches to limiting psychiatrists' liability for their patients' violent acts. Am J Psychiatry 1989;146:821-8.
48. Slovenko R. The therapist's duty to warn or protect endangered third persons. J Psychiatry Law 1988;16:134-209.
49. Beck JC. Current status of the duty to protect. In: Beck JC, ed. Confidentiality versus the duty to protect: foreseeable harm in the practice of psychiatry. Washington, DC: American Psychiatric Press; 1990:9-12.
50. Underwood v United States, 356 F2d 92 (5th Cir 1966).
51. Sparr LF, Drummond DJ. Risk management in Veterans Administration mental health clinics. In: Simon RI, ed. American Psychiatric Press review of clinical psychiatry and the law, vol 3. Washington, DC: American Psychiatric Press, 1992:67-97.
52. Zeldow PB, Taub HA. Evaluating psychiatric discharge and aftercare in a VA medical center. Hosp Community Psychiatry 1981;32:57-8.
53. Roy A. Risk factors for suicide in psychiatric patients. Arch Gen Psychiatry 1982;39:1089-95.
54. Simon RI. Concise guide to psychiatry and law for clinicians. Washington, DC: American Psychiatric Press, 1992.
55. Council on Ethical and Judicial Affairs. Council report: ethical issues in managed care. JAMA 1995;273:330-5.
56. Wickline v California, 183 Cal App 3d 1175, 228 Cal Rptr 661 (Cal Ct App 1986).
57. Wilson v Blue Cross of Southern California, 222 Cal App 3d 660 (1990).
58. Sarchett v Blue Cross of California, 729 P2d 267 (Cal 1987).
59. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(12 suppl):1-36.
60. Hirshfeld EB. Practice parameters and the malpractice liabil-ity of physicians. JAMA 1990;263:1556-62.
61. Kellie SE, Kelly JT. Appropriateness criteria: potential usefulness in practice parameters (background report). Chicago: Office of Quality Assurance, American Medical Association, 1990.
62. Hirshfeld EB. Should practice parameters be the standard of care in malpractice litigation? JAMA 1991;266:2886-91.
63. Daly M. Attacking defensive medicine through the utilization of practice parameters: panacea or placebo for the health care reform movement? J Leg Med 1995;16:101-32.